3rd Quarter - Report

VAN SCOYOC ASSOCIATES for ZEBRA TECHNOLOGIES CORP.

Period 3rd Quarter 2020 Filed Oct 19, 2020 Signed by James M. Crum, Vice President

Official filing
Firm
VAN SCOYOC ASSOCIATES
Client
ZEBRA TECHNOLOGIES CORP.
Income
$30,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

Public Law 113-54, Drug Quality and Security Act, Drug labeling implementation Temperature monitoring technology for COVID-19 vaccines

LobbyistCovered position, as disclosed
JAMES M CRUM —

Contacted: HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); SENATE

Consumer Issues/Safety/Products CSP

Public Law 113-54, Drug Quality and Security Act, Drug labeling implementation Temperature monitoring technology for COVID-19 vaccines

LobbyistCovered position, as disclosed
JAMES M CRUM —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.